Byetta and Deep venous thrombosis - a phase IV clinical study of FDA data
Deep venous thrombosis is found among people who take Byetta, especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Byetta and have Deep venous thrombosis. It is created by eHealthMe based on reports of 60,144 people who have side effects when taking Byetta from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
60,144 people reported to have side effects when taking Byetta.
Among them, 133 people (0.22%) have Deep venous thrombosis.
What is Byetta?
Byetta has active ingredients of exenatide synthetic. It is often used in diabetes. eHealthMe is studying from 60,540 Byetta users for its effectiveness, alternative drugs and more.
What is Deep venous thrombosis?
Deep venous thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis) is found to be associated with 3,255 drugs and 2,700 conditions by eHealthMe.
Number of Byetta and Deep venous thrombosis reports submitted per year:
Time on Byetta when people have Deep venous thrombosis *:
Gender of people who have Deep venous thrombosis when taking Byetta*:
Age of people who have Deep venous thrombosis when taking Byetta *:
Common drugs people take besides Byetta *:
Common side effects people have besides Deep venous thrombosis *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Byetta and have Deep venous thrombosis?Check whether Deep venous thrombosis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Deep venous thrombosis and when was it recovered:
Expand to all the drugs that have ingredients of exenatide synthetic:
Alternative drugs to, pros and cons of Byetta:
- Byetta (60,540 reports)
Common Byetta side effects:
- Weight decreased: 14,204 reports
- Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat): 6,471 reports
- Indigestion: 5,127 reports
- Diarrhea: 3,362 reports
- Pancreatitis (inflammation of pancreas): 3,275 reports
- Dizziness: 3,213 reports
Browse all side effects of Byetta:a b c d e f g h i j k l m n o p q r s t u v w x y z
Deep venous thrombosis treatments and more:
- Deep venous thrombosis (122,343 reports)
COVID vaccines that are related to Deep venous thrombosis:
- Deep venous thrombosis in Moderna COVID Vaccine
- Deep venous thrombosis in Pfizer BioNTech Covid Vaccine
- Deep venous thrombosis in Johnson and Johnson Covid Vaccine
Common drugs associated with Deep venous thrombosis:
- Yasmin: 10,228 reports
- Yaz: 8,816 reports
- Prednisone: 4,625 reports
- Revlimid: 4,573 reports
- Nuvaring: 4,554 reports
- Xarelto: 4,522 reports
- Aspirin: 4,056 reports
- Ibu: 2,932 reports
- Profen: 2,922 reports
- Ibuprofen: 2,922 reports
All the drugs that are associated with Deep venous thrombosis:
- Deep venous thrombosis (3,255 drugs)
Common conditions associated with Deep venous thrombosis:
- Birth control: 7,875 reports
- Multiple myeloma: 5,828 reports
- Pain: 3,489 reports
- High blood pressure: 3,159 reports
All the conditions that are associated with Deep venous thrombosis:
- Deep venous thrombosis (2,700 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on exenatide synthetic (the active ingredients of Byetta) and Byetta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Singulair and Jakafi drug interaction - 4 seconds ago
- Alprazolam and Warm Type Haemolytic Anaemia - 4 seconds ago
- Excedrin and Urinary Incontinence - 8 seconds ago
- Singulair and Cortisone Acetate drug interaction - 9 seconds ago
- Methotrexate and Tension Headache - 11 seconds ago
- Singulair and Foradil drug interaction - 14 seconds ago
- Singulair and Tysabri drug interaction - 15 seconds ago
- Singulair and Rebif drug interaction - 16 seconds ago
- Docefrez and Aspirin drug interaction - 17 seconds ago
- Singulair and Vitamin E drug interaction - 18 seconds ago